Form 8-K - Current report:
SEC Accession No. 0000950170-25-065057
Filing Date
2025-05-07
Accepted
2025-05-07 08:28:56
Documents
12
Period of Report
2025-05-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K hura-20250505.htm   iXBRL 8-K 92961
2 EX-10.1 hura-ex10_1.htm EX-10.1 74567
  Complete submission text file 0000950170-25-065057.txt   316105

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT hura-20250505.xsd EX-101.SCH 30874
15 EXTRACTED XBRL INSTANCE DOCUMENT hura-20250505_htm.xml XML 4717
Mailing Address 10500 UNIVERSITY CENTER DR. SUITE 110 TAMPA FL 33612
Business Address 10500 UNIVERSITY CENTER DR. SUITE 110 TAMPA FL 33612 813-875-6600
TuHURA Biosciences, Inc./NV (Filer) CIK: 0001498382 (see all company filings)

EIN.: 990360497 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37823 | Film No.: 25919440
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)